Remove 2022 Remove Compound Screening Remove Regulations Remove Treatment
article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

The Market After over two years of the Covid-19 pandemic, 2022 year was somewhat of a return to normal for both the world at large and the pharmaceutical industry. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities. However, that is not to say it was an easy year.

article thumbnail

AI use in repurposing drugs for Covid-19

Drug Discovery World

The Covid-19 pandemic demonstrated the power of the scientific community to rapidly mobilise resources and accelerate vaccines and treatments using novel technologies. At Recursion, we saw this emerging health crisis as an opportunity to redirect our artificial intelligence (AI)-powered platform to identify potential treatments.